Epithelioid sarcoma expresses epidermal growth factor receptor but gene amplification and kinase domain mutations are rare. (Q34095970)

31 July 2017

title

Epithelioid sarcoma expresses epidermal growth factor receptor but gene amplification and kinase domain mutations are rare. (English)

1 reference

31 July 2017

1 reference

Michael J Cascio

1

1 reference

31 July 2017

Richard J O'Donnell

series ordinal

2

1 reference

31 July 2017

Andrew E Horvai

series ordinal

3

1 reference

31 July 2017

language of work or name

1 reference

29 January 2010

1 reference

31 July 2017

1 reference

31 July 2017

volume

23

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

574-580

1 reference

Epithelioid sarcoma.A sarcoma simulating a granuloma or a carcinoma

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Epithelioid sarcoma: a case report with ultrastructural confirmation of myofibroblastic differentiation based on fibronexus junctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Epithelioid sarcoma of Enzinger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Update in antiepidermal growth factor receptor therapy in the management of metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Aberration of epidermal growth factor receptor expression in bone and soft-tissue tumors: protein overexpression, gene amplification and activation of downstream molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Mutations in the tyrosine kinase domain of the EGFR gene are rare in synovial sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Epithelioid sarcoma: the clinicopathological complexities of this rare soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Gene expression profiling of human sarcomas: insights into sarcoma biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

Epithelioid sarcoma: the spectrum of ultrastructural differentiation in seven immunohistochemically defined cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

7 January 2021

Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

7 January 2021

Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization–Positive/Phospho-Akt–Positive or Never Smoker Patients With Advanced Non–Small-Cell Lung Cancer: The ONCOBELL Trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

7 January 2021

Evidence for increased epidermal growth factor receptors in human sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

7 January 2021

Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

7 January 2021

Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

7 January 2021

Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

7 January 2021

EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

7 January 2021

Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.2

7 January 2021

Identifiers

DOI

10.1038/MODPATHOL.2010.2

1 reference

Dimensions Publication ID

31 July 2017

1043040342

0 references

1 reference